Access the full text.
Sign up today, get DeepDyve free for 14 days.
HS Nelson (2004)
Advances in upper airway diseases and allergen immunotherapyJ Allergy Clin Immunol, 113
C Mirone, F Albert, A Tosi (2004)
Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebocontrolled studyClin Exp Allergy, 34
GB Pajno, G Passalacqua, D Vita (2004)
Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trialAllergy, 59
C Rolinck-Werninghaus, H Wolf, C Liebke (2004)
A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollenAllergy, 59
DW Aaronson, TK Gandhi (2004)
Incorrect allergy injections: allergists’ experiences and recommendations for preventionJ Allergy Clin Immunol, 113
ML Levy, D Price, X Zheng (2004)
Inadequacies in UK primary care allergy services: national survey of current provisions and perceptions of needClin Exp Allergy, 34
AP Williams, MT Krishna, AJ Frew (2004)
The safety of immunotherapyClin Exp Allergy, 34
G Passalacqua, L Guerra, M Pasquali (2004)
Efficacy and safety of sublingual immunotherapyAnn Allergy Asthma Immunol, 93
G Passalacqua, C Lombardi, GW Canonica (2004)
Sublingual immunotherapy: an updateCurr Opin Allergy Clin Immunol, 4
Stephen T. Holgate, MD Moreno C, Cuesta-Herranz J, Fernárdez-Jávora L, reactions. In trying to identify specific risk factors for Alvarez-Cuesta E on behalf of the SEAIC: Immuno- systemic reactions, five patients experienced more than therapy safety: a prospective multi-centre monitor- three reactions out of a total of 36 from the whole patient ing study of biologically standardised therapeutic group. Severe reactions were observed in those with vaccines for allergic disease. Clin Exp Allergy 2004, diagnosed asthma, with mite > pollen SIT. 34:527–531. Rating: Of importance. Editor’s comments Introduction: Recognizing that systemic and, to a lesser Clearly, for any treatment, one would wish for no side effects degree, local side effects remain a potential barrier to the to occur. This study, along with others [1–3] confirms that, widespread uptake of injection-specific immunotherapy in well-trained hands, SIT has an acceptable safety profile (SIT), this study was carried out in 14 allergy departments when compared with other types of treatment. Nevertheless, from Spain to investigate the current situation when the side effects did occur. These were usually mild and easily therapy is administered by properly trained personnel. reversed with either an antihistamine, or in the case of The study was conducted from
Current Allergy and Asthma Reports – Springer Journals
Published: May 28, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.